Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back


Prabagaran Narayanasamy

University of Nebraska, USA.

Biography

Dr. Prabagaran Narayanasamy is a faculty member in the Department of Pathology and Microbiology at the University of Nebraska Medical Center. He received his Ph. D at IIT in Organic Chemistry and did his postdoctoral studies at North Dakota State University, Harvard University and University of Illinois Urbana-champaign. Later, he joined as a Research Scientist at Colorado State University to explore drug discovery. He has been a faculty at University of Nebraska Medical Center since 2011. Dr. Narayanasamy’s research interests are on development, delivering and discovering drug for anti-mycobacterial medicine and antiretroviral therapy. For antibacterial drug discovery - glyoxalase, quorum sensing, MEP and menaquinone pathway are utilized. For antiviral drug discovery NRTI concept is used. Conventional (HIV and TB) drugs and new inhibitors are used in nanoformulation to generate active nanomedicine for sustained drug release through macrophages. In vitro and In vivo characterizations of drug like compounds were also carried out. In addition, metabolites are evaluated in the infected brain for characterizing neurodegenerative disorders. He has funding from NIH and also in study sections.

Abstract

Abstract : Novel methodology and drug to treat HIV-mycobacterium co-infection